AARP Report Says Brand Name Drugs Spiked Up in Price
The average manufacturer price increases for popular name brand and specialty prescription drugs used by Medicare beneficiaries rose faster than other consumer goods and services in the 12 months ending March 2010, according to a report from AARP's Public Policy Institute.
